COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
By Leroy Leo and Christy Santhosh (Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor of recommending that COVID-19 vaccines for 2024-25 should target a strain within the lineage of the JN.1 variant that has been dominant this year. The 16 advisors did not vote on whether to favor …









